While GHK-Cu is generally well-tolerated in topical research, certain contraindications or precautions should be considered, especially for systemic research or in specific populations: Systemic Research: For systemic applications, GHK-Cu is generally not recommended for subjects who are pregnant, breastfeeding, have active cancer, or suffer from Wilsons disease (a condition involving copper accumulation)
If more than 48 hours have passed, skip the missed dose and resume at the next scheduled time do not double-dose
289 Obesity Obesity is consistently and closely linked to higher risk of atherosclerosis and its thromboembolic complications
It stimulates angiogenesis by forming new blood vessels, attracts nerve and immune cells to injury sites, and exerts antioxidant and anti-inflammatory effects including the reduction of inflammatory cytokines
Given the vastness and uniqueness of individualized compounded formulations, it is impossible to list every potential compound we offer